Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.

Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, Sperling R, Wilcock GK, Fox N, Scheltens P, Touchon J, Hendrix S, Andrieu S, Aisen P; EU/US/CTAD Task Force Members.

Alzheimers Dement. 2013 Jul;9(4):438-44. doi: 10.1016/j.jalz.2013.03.007.

PMID:
23809364
[PubMed - indexed for MEDLINE]
2.

[Prognostic value of N-terminal pro-BNP-type natriuretic peptide in patients with stable coronary heart disease--secondary publication].

Kragelund CB, Grønning BA, Køber L, Hildebrandt PR, Steffensen R.

Ugeskr Laeger. 2006 Feb 13;168(7):697-700. Danish.

PMID:
16494811
[PubMed - indexed for MEDLINE]
3.

[Diagnostic imaging in heart failure].

Grønning BA, Køber L, Kelbaek H.

Ugeskr Laeger. 2004 Jan 19;166(4):255-60. Review. Danish. No abstract available.

PMID:
14964104
[PubMed - indexed for MEDLINE]
4.

[Natriuretic cardiac hormones. Clinical use in heart failure].

Nielsen SJ, Gøtze JP, Raymond IE, Grønning BA, Kirk V, Bay-Nielsen M, Hildebrandt PR, Aldershvile J.

Ugeskr Laeger. 2004 Jan 19;166(4):248-53. Review. Danish. No abstract available.

PMID:
14964102
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk